HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 48186,
"recordsTotal": 48186,
"next": null,
"previous": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&start=47700",
"results": [
{
"registry_id": "NCT07252739",
"publication_url": "https://clinicaltrials.gov/study/NCT07252739",
"title": "KEYMAKER-U01 Substudy 01J: A Randomized Phase 2 Umbrella Study With Rolling Arms of Investigational Agents for First-line Treatment of Participants With Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With KRAS G12C Mutations",
"has_exemption": false,
"start_date": "2025-12-19",
"completion_date": "2033-01-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07250802",
"publication_url": "https://clinicaltrials.gov/study/NCT07250802",
"title": "A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Zasocitinib in Pediatric Participants Aged 4 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis",
"has_exemption": false,
"start_date": "2025-12-04",
"completion_date": "2033-01-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05955508",
"publication_url": "https://clinicaltrials.gov/study/NCT05955508",
"title": "Phase 2 Study of Linvoseltamab in Patients With Smoldering Multiple Myeloma at High Risk of Progression to Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-01-30",
"completion_date": "2033-01-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07456891",
"publication_url": "https://clinicaltrials.gov/study/NCT07456891",
"title": "An Open-label, Multi-center Protocol for Patients Who Have Completed a Previous Novartis Sponsored Remibrutinib Study and Are Judged by the Investigator to Benefit From Continued Treatment With Remibrutinib.",
"has_exemption": false,
"start_date": "2026-04-10",
"completion_date": "2033-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03003299",
"publication_url": "https://clinicaltrials.gov/study/NCT03003299",
"title": "A Prospective, Single-Arm, Multicenter Study to Investigate the Safety and Effectiveness of SAPIEN 3/SAPIEN 3 Ultra Transcatheter Heart Valve Implantation in Patients With a Failing Aortic Bioprosthetic Valve",
"has_exemption": false,
"start_date": "2017-01-05",
"completion_date": "2033-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Edwards Lifesciences",
"sponsor_slug": "edwards-lifesciences",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06048159",
"publication_url": "https://clinicaltrials.gov/study/NCT06048159",
"title": "TACS for the Recovery of Phonological STM After Stroke",
"has_exemption": false,
"start_date": "2023-11-06",
"completion_date": "2033-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07232030",
"publication_url": "https://clinicaltrials.gov/study/NCT07232030",
"title": "Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure (BENEFIT-HF)",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2033-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "CVRx, Inc.",
"sponsor_slug": "cvrx-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07383441",
"publication_url": "https://clinicaltrials.gov/study/NCT07383441",
"title": "Phase III Double Blinded Trial of Immune-Based Therapy With a Live Biotherapeutic MO-03 or Placebo for Frontline Therapy of Advanced Clear Cell Renal Cell Carcinoma [BioFront Trial]",
"has_exemption": false,
"start_date": "2026-06-10",
"completion_date": "2033-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07237269",
"publication_url": "https://clinicaltrials.gov/study/NCT07237269",
"title": "Abiraterone/Prednisone + Standard ADT vs Standard ADT for Prostate Cancer Patients With PSMA-Positive Conventional Imaging Negative Pelvic Lymphadenopathy",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2033-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Nebraska",
"sponsor_slug": "university-of-nebraska",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07195734",
"publication_url": "https://clinicaltrials.gov/study/NCT07195734",
"title": "A Phase II Randomized Trial of Neoadjuvant Chemotherapy or Chemo-Immunotherapy in Patients With Recurrent/Persistent PD-L1 Enriched Squamous Cell Carcinoma of the Head and Neck Undergoing Salvage Surgery (NEOPOLIS)",
"has_exemption": false,
"start_date": "2026-10-09",
"completion_date": "2033-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223697",
"publication_url": "https://clinicaltrials.gov/study/NCT07223697",
"title": "An Extension Study To Evaluate the Long-Term Safety and Efficacy of Afimkibart (RO7790121) in Patients With Atopic Dermatitis Who Participated in Previous Afimkibart Clinical Trials",
"has_exemption": false,
"start_date": "2026-01-08",
"completion_date": "2033-02-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07354074",
"publication_url": "https://clinicaltrials.gov/study/NCT07354074",
"title": "A Phase II, Multicenter, Open-label, Single Arm Study to Evaluate the Safety and Efficacy of Asciminib in Pediatric Participants Newly Diagnosed or Previously Treated With Philadelphia Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) With or Without Known T315I Mutation",
"has_exemption": false,
"start_date": "2026-06-04",
"completion_date": "2033-02-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07318558",
"publication_url": "https://clinicaltrials.gov/study/NCT07318558",
"title": "A Phase 3, Randomized, Open-label, Multicenter Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) Maintenance Treatment With or Without Bevacizumab Versus Standard of Care in Participants With Newly Diagnosed Advanced Non-HRD Positive Ovarian Cancer Following First-line Platinum-based Chemotherapy (TroFuse-021/ENGOTov85/GOG-3102)",
"has_exemption": false,
"start_date": "2026-02-16",
"completion_date": "2033-02-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06465199",
"publication_url": "https://clinicaltrials.gov/study/NCT06465199",
"title": "A Dose Escalation Study Using Eflornithine (DFMO) and AMXT 1501 Followed by a Randomized Controlled Trial of DFMO With or Without AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas",
"has_exemption": false,
"start_date": "2026-03-28",
"completion_date": "2033-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Milton S. Hershey Medical Center",
"sponsor_slug": "milton-s-hershey-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06966700",
"publication_url": "https://clinicaltrials.gov/study/NCT06966700",
"title": "A Phase 3, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2033-03-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03761108",
"publication_url": "https://clinicaltrials.gov/study/NCT03761108",
"title": "Phase 1/2 FIH Study of REGN5458 (Anti-BCMA x Anti-CD3 Bispecific Antibody) in Patients With Relapsed or Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2019-01-23",
"completion_date": "2033-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05786066",
"publication_url": "https://clinicaltrials.gov/study/NCT05786066",
"title": "The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects",
"has_exemption": false,
"start_date": "2023-04-03",
"completion_date": "2033-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05929768",
"publication_url": "https://clinicaltrials.gov/study/NCT05929768",
"title": "Shorter Anthracycline-Free Chemo Immunotherapy Adapted to Pathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III Study",
"has_exemption": false,
"start_date": "2023-09-15",
"completion_date": "2033-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06952803",
"publication_url": "https://clinicaltrials.gov/study/NCT06952803",
"title": "A Randomised, Double-blind, Placebo-controlled, Phase III Study of Adjuvant Saruparib (AZD5305) in Patients With BRCAm Localised High-Risk Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy (EvoPAR-Prostate02).",
"has_exemption": false,
"start_date": "2025-08-06",
"completion_date": "2033-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07007065",
"publication_url": "https://clinicaltrials.gov/study/NCT07007065",
"title": "A Randomized, Controlled, Partially Masked, Phase 3b Study to Assess the Injection Burden, Efficacy, Safety, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec (ABBV-RGX-314) in a Real-World Context in Subjects With Neovascular Age-Related Macular Degeneration (nAMD)",
"has_exemption": false,
"start_date": "2025-11-05",
"completion_date": "2033-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05705453",
"publication_url": "https://clinicaltrials.gov/study/NCT05705453",
"title": "Epidural Stimulation After Neurologic Damage: Long-Term Outcomes",
"has_exemption": false,
"start_date": "2023-03-01",
"completion_date": "2033-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05730036",
"publication_url": "https://clinicaltrials.gov/study/NCT05730036",
"title": "An Open-label, Randomized, Phase 3 Study of Linvoseltamab (REGN5458; Anti- BCMA x Anti-CD3 Bispecific Antibody) Versus the Combination of Elotuzumab, Pomalidomide, and Dexamethasone (EPd), in Patients With Relapsed/Refractory Multiple Myeloma (LINKER-MM3)",
"has_exemption": false,
"start_date": "2023-09-18",
"completion_date": "2033-04-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01742299",
"publication_url": "https://clinicaltrials.gov/study/NCT01742299",
"title": "An Open Label, Multi-center Imatinib Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Imatinib Study and Are Judged by the Investigator to Benefit From Continued Imatinib Treatment",
"has_exemption": false,
"start_date": "2013-03-26",
"completion_date": "2033-04-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05505643",
"publication_url": "https://clinicaltrials.gov/study/NCT05505643",
"title": "COOL-IT: Cryoablation vs Lumpectomy in T1 Breast Cancers: A Randomized Controlled Trial With Safety Lead-in",
"has_exemption": false,
"start_date": "2024-04-03",
"completion_date": "2033-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01796795",
"publication_url": "https://clinicaltrials.gov/study/NCT01796795",
"title": "A Double-blind, Randomized, Vehicle-controlled, Parallel-group, Phase II Dose-ranging Study to Evaluate the Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients.",
"has_exemption": false,
"start_date": "2030-09-30",
"completion_date": "2033-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "G&E Herbal Biotechnology Co., LTD",
"sponsor_slug": "ge-herbal-biotechnology-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05899673",
"publication_url": "https://clinicaltrials.gov/study/NCT05899673",
"title": "A Phase 3, Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Fazirsiran in Participants With Alpha-1 Antitrypsin Deficiency-Associated Liver Disease",
"has_exemption": false,
"start_date": "2023-08-08",
"completion_date": "2033-05-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07286292",
"publication_url": "https://clinicaltrials.gov/study/NCT07286292",
"title": "A Phase 2, Single Arm, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Vorasidenib in Pediatric Participants Aged 12 to < 18 Years Old With Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation",
"has_exemption": false,
"start_date": "2026-03-15",
"completion_date": "2033-05-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Institut de Recherches Internationales Servier (I.R.I.S.)",
"sponsor_slug": "institut-de-recherches-internationales-servier-iris",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06623422",
"publication_url": "https://clinicaltrials.gov/study/NCT06623422",
"title": "A Phase 3 Randomized Double-blind Study of Adjuvant Pembrolizumab With or Without V940 in Participants With Resectable Stage II to IIIB (N2) NSCLC Not Achieving pCR After Receiving Neoadjuvant Pembrolizumab With Platinum-based Doublet Chemotherapy (INTerpath-009)",
"has_exemption": false,
"start_date": "2024-10-21",
"completion_date": "2033-05-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02339571",
"publication_url": "https://clinicaltrials.gov/study/NCT02339571",
"title": "Randomized Phase II/III Study of Nivolumab Plus Ipilimumab Plus Sargramostim Versus Nivolumab Plus Ipilimumab in Patients With Unresectable Stage III or Stage IV Melanoma",
"has_exemption": false,
"start_date": "2015-11-23",
"completion_date": "2033-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04307576",
"publication_url": "https://clinicaltrials.gov/study/NCT04307576",
"title": "ALLTogether1 - A Treatment Study Protocol of the ALLTogether Consortium for Children and Young Adults (0-45 Years of Age) With Newly Diagnosed Acute Lymphoblastic Leukaemia (ALL)",
"has_exemption": false,
"start_date": "2020-07-13",
"completion_date": "2033-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mats Heyman",
"sponsor_slug": "mats-heyman",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05257083",
"publication_url": "https://clinicaltrials.gov/study/NCT05257083",
"title": "A Phase 3 Randomized Study Comparing Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible",
"has_exemption": false,
"start_date": "2023-10-10",
"completion_date": "2033-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stichting European Myeloma Network",
"sponsor_slug": "stichting-european-myeloma-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05565105",
"publication_url": "https://clinicaltrials.gov/study/NCT05565105",
"title": "A Phase II Trial of CD34+ Enriched Transplants From HLA-Compatible Related or Unrelated Donors for Treatment of Patients With Leukemia or Lymphoma",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2033-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Guenther Koehne",
"sponsor_slug": "guenther-koehne",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05617625",
"publication_url": "https://clinicaltrials.gov/study/NCT05617625",
"title": "A Phase II Trial of CD34+ Enriched Transplants From HLA-Compatible Related or Unrelated Donors for Treatment of Patients With Myelodysplastic Syndrome",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2033-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Guenther Koehne",
"sponsor_slug": "guenther-koehne",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06236724",
"publication_url": "https://clinicaltrials.gov/study/NCT06236724",
"title": "Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.",
"has_exemption": false,
"start_date": "2024-01-31",
"completion_date": "2033-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07060807",
"publication_url": "https://clinicaltrials.gov/study/NCT07060807",
"title": "An Open-label, Randomized, Phase 3 Study to Evaluate Patritumab Deruxtecan Monotherapy Versus Treatment of Physician's Choice in Hormone Receptor-positive, HER2-negative Unresectable Locally Advanced or Metastatic Breast Cancer (HERTHENA-Breast04)",
"has_exemption": false,
"start_date": "2025-07-21",
"completion_date": "2033-07-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05803941",
"publication_url": "https://clinicaltrials.gov/study/NCT05803941",
"title": "A Phase IV, Post-Authorization Safety Study to Investigate the Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Adult Participants With Prostate Cancer",
"has_exemption": false,
"start_date": "2023-08-14",
"completion_date": "2033-07-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07393282",
"publication_url": "https://clinicaltrials.gov/study/NCT07393282",
"title": "A Phase 3, Randomized, Open-Label Study of Linvoseltamab Versus Daratumumab in Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma",
"has_exemption": false,
"start_date": "2026-03-25",
"completion_date": "2033-07-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04510597",
"publication_url": "https://clinicaltrials.gov/study/NCT04510597",
"title": "Phase III Trial of Immunotherapy-Based Combination Therapy With or Without Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma (PROBE Trial)",
"has_exemption": false,
"start_date": "2021-03-08",
"completion_date": "2033-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04984291",
"publication_url": "https://clinicaltrials.gov/study/NCT04984291",
"title": "Zimmer Biomet Shoulder Arthroplasty Long-term Post Market Clinical Follow-up Study",
"has_exemption": false,
"start_date": "2021-07-28",
"completion_date": "2033-08-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01736592",
"publication_url": "https://clinicaltrials.gov/study/NCT01736592",
"title": "An Open Label Study to Determine the Long Term Safety, Tolerability and Biological Activity of SAR422459 in Patients With Stargardt's Macular Degeneration",
"has_exemption": false,
"start_date": "2012-12-14",
"completion_date": "2033-08-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT07326592",
"publication_url": "https://clinicaltrials.gov/study/NCT07326592",
"title": "A Phase 4, Multicenter, Double-blind, Study to Investigate the Efficacy, Safety, and Tolerability of 3 Active Doses of Respreeza® / Zemaira® Weekly Intravenous Infusions Administered Over 3 Years as Longterm Maintenance Therapy in Adult Subjects With Emphysema Related to Alpha1 Antitrypsin Deficiency",
"has_exemption": false,
"start_date": "2026-04-15",
"completion_date": "2033-09-15",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06055712",
"publication_url": "https://clinicaltrials.gov/study/NCT06055712",
"title": "Antibiotic Prophylaxis in Pediatric Open Fractures",
"has_exemption": false,
"start_date": "2023-09-11",
"completion_date": "2033-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Louis University",
"sponsor_slug": "st-louis-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07192432",
"publication_url": "https://clinicaltrials.gov/study/NCT07192432",
"title": "A Phase 1/2, First-in-Human Study of VNX-202 Gene Therapy in Patients With HER2-Positive Cancer",
"has_exemption": false,
"start_date": "2025-11-18",
"completion_date": "2033-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vironexis Biotherapeutics Inc.",
"sponsor_slug": "vironexis-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07455851",
"publication_url": "https://clinicaltrials.gov/study/NCT07455851",
"title": "A FIH Phase 1/2 Study to Assess Safety, Tolerability, and Preliminary Anti-Tumor Activity of REGN17372, an Anti-GPRC5D x Anti-CD28 Costimulatory Bispecific Monoclonal Antibody, in Combination With Linvoseltamab, an Anti-BCMA x Anti-CD3 Bispecific Monoclonal Antibody, in Participants With Relapsed/Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2026-03-23",
"completion_date": "2033-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07080905",
"publication_url": "https://clinicaltrials.gov/study/NCT07080905",
"title": "Phase 3, Open-label, Single-dose, Multicenter Study Investigating Efficacy, Safety, and Tolerability of CSL222 (Etranacogene Dezaparvovec) Administered to Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B",
"has_exemption": false,
"start_date": "2025-07-28",
"completion_date": "2033-10-24",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04636190",
"publication_url": "https://clinicaltrials.gov/study/NCT04636190",
"title": "A Retrospectively Enrolled and Prospectively Followed, Post-market, Multi-center Evaluation of the Clinical Outcomes of the Triathlon All-Polyethylene Tibia",
"has_exemption": false,
"start_date": "2021-07-02",
"completion_date": "2033-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stryker Orthopaedics",
"sponsor_slug": "stryker-orthopaedics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05967351",
"publication_url": "https://clinicaltrials.gov/study/NCT05967351",
"title": "A Phase 3, Multinational, Long-term Follow-up Study to Evaluate Safety and Efficacy in Subjects Who Have Previously Received SRP-9001 in a Clinical Study",
"has_exemption": false,
"start_date": "2023-09-27",
"completion_date": "2033-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sarepta Therapeutics, Inc.",
"sponsor_slug": "sarepta-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05994235",
"publication_url": "https://clinicaltrials.gov/study/NCT05994235",
"title": "A Phase II Trial of Tazemetostat Plus Mosunetuzumab in Untreated Follicular Lymphoma",
"has_exemption": false,
"start_date": "2023-11-01",
"completion_date": "2033-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06339320",
"publication_url": "https://clinicaltrials.gov/study/NCT06339320",
"title": "Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity",
"has_exemption": false,
"start_date": "2024-02-28",
"completion_date": "2033-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The Methodist Hospital Research Institute",
"sponsor_slug": "the-methodist-hospital-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05660408",
"publication_url": "https://clinicaltrials.gov/study/NCT05660408",
"title": "RNA PRIME - RNA Lipid Particles Targeting Pediatric Recurrent Intracranial Malignancies and Other systEmic Solid Tumors",
"has_exemption": false,
"start_date": "2025-03-12",
"completion_date": "2033-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03755739",
"publication_url": "https://clinicaltrials.gov/study/NCT03755739",
"title": "A Phase II/III Trial of Comparison of Benefit of Administration of Checkpoint Inhibitors Plus Chemodrug Via Artery or Fine Needle to Tumor Versus Vein for Immunotherapy of Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2018-11-01",
"completion_date": "2033-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Second Affiliated Hospital of Guangzhou Medical University",
"sponsor_slug": "second-affiliated-hospital-of-guangzhou-medical-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06368817",
"publication_url": "https://clinicaltrials.gov/study/NCT06368817",
"title": "A Phase II Trial Evaluating Chemotherapy Followed by Response-Based Reduced Radiation Therapy for Patients With Central Nervous System Germinomas",
"has_exemption": false,
"start_date": "2024-10-22",
"completion_date": "2033-11-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06669247",
"publication_url": "https://clinicaltrials.gov/study/NCT06669247",
"title": "A First-in-Human (FIH) Phase 1/2 Study to Assess Safety, Tolerability, and Preliminary Anti-Tumor Activity of REGN7945, an Anti-CD38 x Anti-CD28 Costimulatory Bispecific Monoclonal Antibody, in Combination With Linvoseltamab, an Anti-BCMA x Anti-CD3 Bispecific Monoclonal Antibody, in Participants With Relapsed/Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-12-11",
"completion_date": "2033-11-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04742634",
"publication_url": "https://clinicaltrials.gov/study/NCT04742634",
"title": "A Phase I/II Trial of Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant",
"has_exemption": false,
"start_date": "2022-05-12",
"completion_date": "2033-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07058077",
"publication_url": "https://clinicaltrials.gov/study/NCT07058077",
"title": "An Operationally Seamless Phase 2/3 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Enlicitide Decanoate in Pediatric Participants With Heterozygous Familial Hypercholesterolemia",
"has_exemption": false,
"start_date": "2025-08-21",
"completion_date": "2033-12-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05642195",
"publication_url": "https://clinicaltrials.gov/study/NCT05642195",
"title": "Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-03-24",
"completion_date": "2033-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04513717",
"publication_url": "https://clinicaltrials.gov/study/NCT04513717",
"title": "Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)",
"has_exemption": false,
"start_date": "2021-01-21",
"completion_date": "2033-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NRG Oncology",
"sponsor_slug": "nrg-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04754087",
"publication_url": "https://clinicaltrials.gov/study/NCT04754087",
"title": "Global, Multicenter, and Prospective Post-Market Clinical Follow-Up Study of the G7 Acetabular System With Vivacit-E and Longevity Highly Crosslinked Polyethylene (HXLPE) Liners & Instrumentation",
"has_exemption": false,
"start_date": "2021-07-07",
"completion_date": "2033-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07220902",
"publication_url": "https://clinicaltrials.gov/study/NCT07220902",
"title": "Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure: A Randomized Controlled Trial \"LEVMag Trial\"",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2033-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nebraska Methodist Health System",
"sponsor_slug": "nebraska-methodist-health-system",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07321847",
"publication_url": "https://clinicaltrials.gov/study/NCT07321847",
"title": "Intratumoral Injection of IP-001 Following Standard-of-care Complete Hepatic Tumor Ablation in Patients With Liver-only Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2033-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Immunophotonics, Inc.",
"sponsor_slug": "immunophotonics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05951205",
"publication_url": "https://clinicaltrials.gov/study/NCT05951205",
"title": "A Phase 3 Study to Evaluate Efficacy and Safety of a Single Dose of Exa-cel in Subjects With Severe Sickle Cell Disease, βS/βC Genotype",
"has_exemption": false,
"start_date": "2027-07-31",
"completion_date": "2033-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vertex Pharmaceuticals Incorporated",
"sponsor_slug": "vertex-pharmaceuticals-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07405164",
"publication_url": "https://clinicaltrials.gov/study/NCT07405164",
"title": "A Multicenter, Open-label, Phase 3 Extension Study to Evaluate the Long-term Efficacy and Safety in Participants Who Are Currently on Treatment in a Belzutifan Study (LITESPARK-043)",
"has_exemption": false,
"start_date": "2026-03-23",
"completion_date": "2034-01-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02106988",
"publication_url": "https://clinicaltrials.gov/study/NCT02106988",
"title": "Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Patients With Stage I/II Nasal NK Cell Lymphoma",
"has_exemption": false,
"start_date": "2015-01-16",
"completion_date": "2034-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06591819",
"publication_url": "https://clinicaltrials.gov/study/NCT06591819",
"title": "Safety of Hypofractionated Whole-Pelvis Proton Therapy With HDR Boost",
"has_exemption": false,
"start_date": "2025-01-15",
"completion_date": "2034-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Abramson Cancer Center at Penn Medicine",
"sponsor_slug": "abramson-cancer-center-at-penn-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06312137",
"publication_url": "https://clinicaltrials.gov/study/NCT06312137",
"title": "A Phase 3 Randomized Open-Label Study of Adjuvant Pembrolizumab With or Without MK-2870 in Participants With Resectable Stage II to IIIB (N2) NSCLC Not Achieving pCR After Receiving Neoadjuvant Pembrolizumab With Platinum-based Doublet Chemotherapy Followed by Surgery",
"has_exemption": false,
"start_date": "2024-04-03",
"completion_date": "2034-02-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05552157",
"publication_url": "https://clinicaltrials.gov/study/NCT05552157",
"title": "A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled, Two-Stage Adaptive Design, Platform Trial of Investigational Treatments for Primary Prevention of Disease Progression in Dominantly Inherited Alzheimer's Disease",
"has_exemption": false,
"start_date": "2024-11-22",
"completion_date": "2034-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06337032",
"publication_url": "https://clinicaltrials.gov/study/NCT06337032",
"title": "An Open-label, Single-arm Study to Provide Continued Access to Study Drug to Participants Who Have Completed Pediatric Clinical Studies Involving Gilead HIV Treatments",
"has_exemption": false,
"start_date": "2024-08-27",
"completion_date": "2034-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06647498",
"publication_url": "https://clinicaltrials.gov/study/NCT06647498",
"title": "A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled, Two-Stage Adaptive Design, Platform Trial of Investigational Treatments for Primary Prevention of Disease Progression in Dominantly Inherited Alzheimer's Disease",
"has_exemption": false,
"start_date": "2024-11-22",
"completion_date": "2034-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05144191",
"publication_url": "https://clinicaltrials.gov/study/NCT05144191",
"title": "Insignia™ Hip Stem Outcomes Study - A Prospective, Post-market, Multi-center Evaluation of the Clinical Outcomes of the Insignia™ Hip Stem for Total Hip Replacement Surgery",
"has_exemption": false,
"start_date": "2022-02-07",
"completion_date": "2034-04-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Stryker Orthopaedics",
"sponsor_slug": "stryker-orthopaedics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05295433",
"publication_url": "https://clinicaltrials.gov/study/NCT05295433",
"title": "A Phase 1/2, Global, Open-Label, Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705",
"has_exemption": false,
"start_date": "2022-03-08",
"completion_date": "2034-04-02",
"has_results": false,
"results_due": false,
"sponsor_name": "ModernaTX, Inc.",
"sponsor_slug": "modernatx-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06559540",
"publication_url": "https://clinicaltrials.gov/study/NCT06559540",
"title": "SWIFT RT: Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast Cancer",
"has_exemption": false,
"start_date": "2024-08-27",
"completion_date": "2034-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06264388",
"publication_url": "https://clinicaltrials.gov/study/NCT06264388",
"title": "A Biomarker-Guided Phase 2 Study of DB107-RRV (Retroviral Replicating Vector) Combined With DB107-Flucytosine Extended-Release Tablets in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma",
"has_exemption": false,
"start_date": "2024-05-01",
"completion_date": "2034-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Ashish Shah",
"sponsor_slug": "ashish-shah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06400342",
"publication_url": "https://clinicaltrials.gov/study/NCT06400342",
"title": "Randomized Evaluation of Valve-In-Valve Versus Explantation for Failed TAVR (REVIVE-TAVR)",
"has_exemption": false,
"start_date": "2025-03-01",
"completion_date": "2034-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medstar Health Research Institute",
"sponsor_slug": "medstar-health-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04817969",
"publication_url": "https://clinicaltrials.gov/study/NCT04817969",
"title": "Persona® Ti-Nidium® Personalized Total Knee System A Post-Market Clinical Follow-up Study to Provide Safety, Performance and Clinical Benefits Data Using the Persona Ti-Nidium Total Knee System and Instrumentation",
"has_exemption": false,
"start_date": "2021-06-01",
"completion_date": "2034-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06289673",
"publication_url": "https://clinicaltrials.gov/study/NCT06289673",
"title": "INITIALL: Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma",
"has_exemption": false,
"start_date": "2024-12-26",
"completion_date": "2034-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07339384",
"publication_url": "https://clinicaltrials.gov/study/NCT07339384",
"title": "Circulating Tumor DNA Assessment in Early-Stage Endometrial Cancer (SIGNAL-EMC 101)",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2034-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Natera, Inc.",
"sponsor_slug": "natera-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06239272",
"publication_url": "https://clinicaltrials.gov/study/NCT06239272",
"title": "NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)",
"has_exemption": false,
"start_date": "2024-03-27",
"completion_date": "2034-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07483632",
"publication_url": "https://clinicaltrials.gov/study/NCT07483632",
"title": "A Phase 3 Study With an Open-Label Extension in Pediatric Participants to Evaluate the Safety, Efficacy, and Pharmacokinetics of Diroximel Fumarate and Dimethyl Fumarate for the Treatment of Relapsing Forms of Multiple Sclerosis",
"has_exemption": false,
"start_date": "2026-11-16",
"completion_date": "2034-07-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Biogen",
"sponsor_slug": "biogen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02791581",
"publication_url": "https://clinicaltrials.gov/study/NCT02791581",
"title": "Understanding and Predicting Breast Cancer Events After Treatment (UPBEAT)",
"has_exemption": false,
"start_date": "2017-07-21",
"completion_date": "2034-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07071519",
"publication_url": "https://clinicaltrials.gov/study/NCT07071519",
"title": "A Phase 3, Multi-Center Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Risankizumab With Open-Label Induction, Randomized Double-Blind Maintenance, and Open-Label Long-Term Extension Periods in Pediatric Subjects (2 to < 18 Years of Age) With Moderately to Severely Active Ulcerative Colitis",
"has_exemption": false,
"start_date": "2025-07-28",
"completion_date": "2034-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05907759",
"publication_url": "https://clinicaltrials.gov/study/NCT05907759",
"title": "A Phase II Study of Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease",
"has_exemption": false,
"start_date": "2024-07-10",
"completion_date": "2034-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06569082",
"publication_url": "https://clinicaltrials.gov/study/NCT06569082",
"title": "CD34+ Selected Donor Cell Boost for Management of Poor Graft Function or Primary or Secondary Graft Failure Following Allogeneic Hematopoietic Stem Cell Transplantation",
"has_exemption": false,
"start_date": "2024-10-31",
"completion_date": "2034-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06085742",
"publication_url": "https://clinicaltrials.gov/study/NCT06085742",
"title": "BRE-08: A Phase II Study of an All-Oral Adjuvant Chemotherapy Regimen of Cyclophosphamide, Methotrexate, and Capecitabine (CMC) for Early-Stage Breast Cancer",
"has_exemption": false,
"start_date": "2023-11-22",
"completion_date": "2034-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05977036",
"publication_url": "https://clinicaltrials.gov/study/NCT05977036",
"title": "BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer",
"has_exemption": false,
"start_date": "2024-09-25",
"completion_date": "2034-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221565",
"publication_url": "https://clinicaltrials.gov/study/NCT07221565",
"title": "ImmuneNet: Quantum-Synaptic Immunotherapy Mapping",
"has_exemption": false,
"start_date": "2025-10-23",
"completion_date": "2034-10-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Truway Health, Inc.",
"sponsor_slug": "truway-health-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06023641",
"publication_url": "https://clinicaltrials.gov/study/NCT06023641",
"title": "A Protocol for the Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease",
"has_exemption": false,
"start_date": "2024-03-13",
"completion_date": "2034-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07291102",
"publication_url": "https://clinicaltrials.gov/study/NCT07291102",
"title": "Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2034-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nationwide Children's Hospital",
"sponsor_slug": "nationwide-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06351631",
"publication_url": "https://clinicaltrials.gov/study/NCT06351631",
"title": "A Multicenter, Open-Label, Extension Study Evaluating the Safety and Efficacy of Bomedemstat for the Treatment of Participants Enrolled in a Prior Bomedemstat Clinical Study",
"has_exemption": false,
"start_date": "2024-05-23",
"completion_date": "2034-12-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06764095",
"publication_url": "https://clinicaltrials.gov/study/NCT06764095",
"title": "CAST-AI: Cystectomy After Systemic Therapy With ADC and Immunotherapy",
"has_exemption": false,
"start_date": "2025-01-08",
"completion_date": "2034-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06851767",
"publication_url": "https://clinicaltrials.gov/study/NCT06851767",
"title": "Phase 1/2 Base-Edited Hematopoietic Stem/Progenitor Cell X-Linked Severe Combined Immunodeficiency Gene Therapy",
"has_exemption": false,
"start_date": "2025-05-09",
"completion_date": "2034-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06926634",
"publication_url": "https://clinicaltrials.gov/study/NCT06926634",
"title": "Zanzalintinib Maintenance in Patients With High Grade Neuroendocrine Neoplasms (HG-NENs)",
"has_exemption": false,
"start_date": "2025-12-09",
"completion_date": "2034-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07256977",
"publication_url": "https://clinicaltrials.gov/study/NCT07256977",
"title": "A Multicenter Non-inferiority Randomized Controlled Trial on Minimally Invasive Radical Hysterectomy Using an Endoscopic Stapler to Prevent Tumor Spillage in Stage IB2-IIA1 Cervical Cancer",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2034-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Seoul National University Hospital",
"sponsor_slug": "seoul-national-university-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07428993",
"publication_url": "https://clinicaltrials.gov/study/NCT07428993",
"title": "A Phase II Study Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2034-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05307146",
"publication_url": "https://clinicaltrials.gov/study/NCT05307146",
"title": "Study of Brain Activity in Candidates for Epilepsy Surgery",
"has_exemption": false,
"start_date": "2013-12-18",
"completion_date": "2035-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Universitaire Ziekenhuizen KU Leuven",
"sponsor_slug": "universitaire-ziekenhuizen-ku-leuven",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT07231471",
"publication_url": "https://clinicaltrials.gov/study/NCT07231471",
"title": "Platelet Rich Plasma for Musculoskeletal Conditions",
"has_exemption": false,
"start_date": "2025-12-15",
"completion_date": "2035-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06820736",
"publication_url": "https://clinicaltrials.gov/study/NCT06820736",
"title": "A Prospective, Randomized Comparison Of Drainage Techniques After One- Or Two-Level Open Posterior Lumbar Decompression Or Decompression And Fusion",
"has_exemption": false,
"start_date": "2025-01-10",
"completion_date": "2035-01-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Twin Cities Spine Center",
"sponsor_slug": "twin-cities-spine-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06826612",
"publication_url": "https://clinicaltrials.gov/study/NCT06826612",
"title": "A Phase 1/2, Randomized, Sequential, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of a One-Time, Bilateral, Intraparenchymal Infusion of SPK-10001 Into the Caudate and Putamen in Participants With Huntington's Disease",
"has_exemption": false,
"start_date": "2025-02-21",
"completion_date": "2035-01-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07444723",
"publication_url": "https://clinicaltrials.gov/study/NCT07444723",
"title": "A Phase II Study of Accuracy of 18F-Fluorocholine PET/MRI and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors",
"has_exemption": false,
"start_date": "2026-03-24",
"completion_date": "2035-02-05",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04174105",
"publication_url": "https://clinicaltrials.gov/study/NCT04174105",
"title": "A Phase 1/2, Open-Label, Ascending-Dose Clinical Study to Evaluate the Safety and Preliminary Efficacy of AT845, an AAV8-Delivered Gene Transfer Therapy in Patients With Late Onset Pompe Disease",
"has_exemption": false,
"start_date": "2020-10-27",
"completion_date": "2035-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Astellas Gene Therapies",
"sponsor_slug": "astellas-gene-therapies",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06931301",
"publication_url": "https://clinicaltrials.gov/study/NCT06931301",
"title": "Effect of Hyperbaric Oxygen Therapy on Osteonecrosis of the Femoral Head When Combined With 3D Navigated Core Decompression With Bone Marrow Aspirate Concentrate",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2035-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06412497",
"publication_url": "https://clinicaltrials.gov/study/NCT06412497",
"title": "MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.",
"has_exemption": false,
"start_date": "2024-06-05",
"completion_date": "2035-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Masonic Cancer Center, University of Minnesota",
"sponsor_slug": "masonic-cancer-center-university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06037356",
"publication_url": "https://clinicaltrials.gov/study/NCT06037356",
"title": "Prostatic Urethral Lift Versus Transurethral Resection of Prostate in Benign Prostatic Hyperplasia Patients With Urinary Retention",
"has_exemption": false,
"start_date": "2025-01-01",
"completion_date": "2035-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Queen Mary Hospital, Hong Kong",
"sponsor_slug": "queen-mary-hospital-hong-kong",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02177721",
"publication_url": "https://clinicaltrials.gov/study/NCT02177721",
"title": "A Field Study to Evaluate the Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure Scenario",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2035-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emergent BioSolutions",
"sponsor_slug": "emergent-biosolutions",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04731077",
"publication_url": "https://clinicaltrials.gov/study/NCT04731077",
"title": "Global, Multicenter, and Prospective Post-Market Clinical Follow-Up Study of the Avenir Complete™ Femoral Stem (Implants and Instrumentation)",
"has_exemption": false,
"start_date": "2021-09-27",
"completion_date": "2035-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06728072",
"publication_url": "https://clinicaltrials.gov/study/NCT06728072",
"title": "Pilot Study Evaluating Microbiome Modulation Therapy (MBMT) With Ciprofloxacin, Metronidazole, and Aspirin in Addition to Standard of Care Chemotherapy in Patients Undergoing First-Line Therapy for Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2025-03-07",
"completion_date": "2035-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Virginia Commonwealth University",
"sponsor_slug": "virginia-commonwealth-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05535166",
"publication_url": "https://clinicaltrials.gov/study/NCT05535166",
"title": "SJiMB21: Phase 2 Study of Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma",
"has_exemption": false,
"start_date": "2022-12-20",
"completion_date": "2035-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01654133",
"publication_url": "https://clinicaltrials.gov/study/NCT01654133",
"title": "Evaluation of Visceral Function Following Endovascular Aortic Aneurysm Repair Using Branched Stent- Grafts",
"has_exemption": false,
"start_date": "2012-07-31",
"completion_date": "2035-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of North Carolina, Chapel Hill",
"sponsor_slug": "university-of-north-carolina-chapel-hill",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT07005024",
"publication_url": "https://clinicaltrials.gov/study/NCT07005024",
"title": "A Comparison of Anticoagulant Dosing Strategies to Reduce VTE and Mortality in Cancer Outpatients: A Randomized, Pragmatic Trial",
"has_exemption": false,
"start_date": "2025-10-17",
"completion_date": "2035-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Vermont",
"sponsor_slug": "university-of-vermont",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06995053",
"publication_url": "https://clinicaltrials.gov/study/NCT06995053",
"title": "Image-Guidance With Triggered Beam Hold To Implanted Fiducial Markers or Hypersight for Stereotactic Body Radiotherapy for Prostate Cancer (ILLUSION)",
"has_exemption": false,
"start_date": "2025-06-27",
"completion_date": "2035-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07072585",
"publication_url": "https://clinicaltrials.gov/study/NCT07072585",
"title": "A Phase 2/3 Randomized Trial Investigating Daratumumab on a Modified Augmented BFM (aBFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LL)",
"has_exemption": false,
"start_date": "2026-06-28",
"completion_date": "2035-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07053436",
"publication_url": "https://clinicaltrials.gov/study/NCT07053436",
"title": "MMRC Horizon Two: A Phase II Randomized Adaptive Platform Trial Integrating Novel Therapies in High-Risk-Newly Diagnosed Multiple Myeloma",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2035-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Multiple Myeloma Research Consortium",
"sponsor_slug": "multiple-myeloma-research-consortium",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07220187",
"publication_url": "https://clinicaltrials.gov/study/NCT07220187",
"title": "A Randomized Phase III Study of Pirtobrutinib Plus R-CHOP vs. R-CHOP for Participants With Previously Untreated Richter Transformation (PIRAMID)",
"has_exemption": false,
"start_date": "2026-05-02",
"completion_date": "2035-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07185165",
"publication_url": "https://clinicaltrials.gov/study/NCT07185165",
"title": "Eclipse: Flotufolastat F 18 to Determine Treatment Success Following Prostate Focal Therapy",
"has_exemption": false,
"start_date": "2025-10-09",
"completion_date": "2035-10-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05128903",
"publication_url": "https://clinicaltrials.gov/study/NCT05128903",
"title": "Quantitative Assessment of Radiation-induced Neuroinflammation - A Proof of Principle Study",
"has_exemption": false,
"start_date": "2022-07-05",
"completion_date": "2035-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03841617",
"publication_url": "https://clinicaltrials.gov/study/NCT03841617",
"title": "The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer",
"has_exemption": false,
"start_date": "2019-07-29",
"completion_date": "2035-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05828511",
"publication_url": "https://clinicaltrials.gov/study/NCT05828511",
"title": "Phase 1/2 Study of Linvoseltamab (Anti-BCMA X Anti-CD3 Bispecific Antibody) in Previously Untreated Patients With Symptomatic Multiple Myeloma",
"has_exemption": false,
"start_date": "2023-12-19",
"completion_date": "2035-11-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03371212",
"publication_url": "https://clinicaltrials.gov/study/NCT03371212",
"title": "A Prospective Randomized Trial of Modular Dual Mobility Acetabular Components Versus Conventional Single Bearing Components in Primary Total Hip Arthroplasty",
"has_exemption": false,
"start_date": "2017-12-15",
"completion_date": "2035-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Rush University Medical Center",
"sponsor_slug": "rush-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07293585",
"publication_url": "https://clinicaltrials.gov/study/NCT07293585",
"title": "Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray Treatment",
"has_exemption": false,
"start_date": "2025-12-16",
"completion_date": "2035-12-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06701760",
"publication_url": "https://clinicaltrials.gov/study/NCT06701760",
"title": "Exogenous Sodium Lactate Infusion in Traumatic Brain Injury (ELI-TBI)",
"has_exemption": false,
"start_date": "2028-01-10",
"completion_date": "2035-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04699591",
"publication_url": "https://clinicaltrials.gov/study/NCT04699591",
"title": "Compassionate Use of Domperidone for Refractory Gastroparesis",
"has_exemption": false,
"start_date": "2013-04-30",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Mercy Hospital Kansas City",
"sponsor_slug": "childrens-mercy-hospital-kansas-city",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02469662",
"publication_url": "https://clinicaltrials.gov/study/NCT02469662",
"title": "Retrospective and Prospective Clinical Outcomes Study of the Zimmer® Nexel™ Total Elbow",
"has_exemption": false,
"start_date": "2015-06-30",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04042025",
"publication_url": "https://clinicaltrials.gov/study/NCT04042025",
"title": "A Long-term Follow-up Study of Patients in the Clinical Trials for Spinal Muscular Atrophy Receiving AVXS-101",
"has_exemption": false,
"start_date": "2020-02-10",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Gene Therapies",
"sponsor_slug": "novartis-gene-therapies",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06697301",
"publication_url": "https://clinicaltrials.gov/study/NCT06697301",
"title": "A Multicenter, Randomized, Double-Blind, Active Comparator-Controlled, Adaptive Phase 2/3 Study to Evaluate the Safety and Efficacy of EIK1001 and Pembrolizumab Versus Placebo and Pembrolizumab as First-Line Therapy in Participants With Advanced Melanoma (TeLuRide-006)",
"has_exemption": false,
"start_date": "2025-05-22",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eikon Therapeutics",
"sponsor_slug": "eikon-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07186634",
"publication_url": "https://clinicaltrials.gov/study/NCT07186634",
"title": "Domain-Specific Appendix: OXYGEN",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Monash University",
"sponsor_slug": "monash-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07282834",
"publication_url": "https://clinicaltrials.gov/study/NCT07282834",
"title": "Randomized Phase II Trial of Heated Vs. Pressurized/Aerosolized Chemotherapy (HIPEC vs. PIPAC) for Peritoneal Carcinomatosis",
"has_exemption": false,
"start_date": "2026-01-05",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Patrick Wagner, MD, FACS",
"sponsor_slug": "patrick-wagner-md-facs",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07240649",
"publication_url": "https://clinicaltrials.gov/study/NCT07240649",
"title": "Emerging Indications for Hyperbaric Oxygen Treatment",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jay C. Buckey Jr.",
"sponsor_slug": "jay-c-buckey-jr",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07447076",
"publication_url": "https://clinicaltrials.gov/study/NCT07447076",
"title": "A Platform Study of Novel Therapies for Children, Adolescents and Young Adults With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sabine Mueller, MD, PhD",
"sponsor_slug": "sabine-mueller-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07365319",
"publication_url": "https://clinicaltrials.gov/study/NCT07365319",
"title": "A Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer (TeLuRide-008).",
"has_exemption": false,
"start_date": "2026-05-18",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eikon Therapeutics",
"sponsor_slug": "eikon-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04074135",
"publication_url": "https://clinicaltrials.gov/study/NCT04074135",
"title": "Evaluation of the Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors",
"has_exemption": false,
"start_date": "2020-06-02",
"completion_date": "2036-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07308886",
"publication_url": "https://clinicaltrials.gov/study/NCT07308886",
"title": "Phase II Study of Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-response (REGIMEN-KS HIV)",
"has_exemption": false,
"start_date": "2026-03-24",
"completion_date": "2036-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02445222",
"publication_url": "https://clinicaltrials.gov/study/NCT02445222",
"title": "Long Term Follow-Up of Patients Exposed to Lentiviral-Based CAR T-Cell Therapy",
"has_exemption": false,
"start_date": "2015-11-02",
"completion_date": "2036-02-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06892522",
"publication_url": "https://clinicaltrials.gov/study/NCT06892522",
"title": "A Phase 1/2, Open-Label, Platform Study to Evaluate Safety and Efficacy of Etentamig Monotherapy or Etentamig Combinations in Subjects With Multiple Myeloma",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2036-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05591859",
"publication_url": "https://clinicaltrials.gov/study/NCT05591859",
"title": "Restoration Anatomic Acetabular Shell Revision Study - A Post-market, Multi-center Evaluation of the Clinical Outcomes of the Restoration Anatomic Acetabular Shell in a Revision Indication",
"has_exemption": false,
"start_date": "2024-03-02",
"completion_date": "2036-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Stryker Orthopaedics",
"sponsor_slug": "stryker-orthopaedics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05767047",
"publication_url": "https://clinicaltrials.gov/study/NCT05767047",
"title": "A Phase 3, Multicenter, Open-label, Long-term Extension Study of Apremilast in Children 2 Years of Age or Older With Oral Ulcers Associated With Behçet's Disease or 5 Years of Age or Older With Juvenile Psoriatic Arthritis",
"has_exemption": false,
"start_date": "2023-03-23",
"completion_date": "2036-03-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07420959",
"publication_url": "https://clinicaltrials.gov/study/NCT07420959",
"title": "Phase 1/2 Trial of ABBV-383 for Patients With Relapsed Refractory Waldenström Macroglobulinemia",
"has_exemption": false,
"start_date": "2026-03-25",
"completion_date": "2036-03-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02201992",
"publication_url": "https://clinicaltrials.gov/study/NCT02201992",
"title": "A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein",
"has_exemption": false,
"start_date": "2015-03-23",
"completion_date": "2036-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03955445",
"publication_url": "https://clinicaltrials.gov/study/NCT03955445",
"title": "An Open-label, Non-randomized Extension Study to Evaluate the Long-term Efficacy, Safety and Tolerability of Iptacopan (LNP023) in C3 Glomerulopathy or Idiopathic Immune-complex-membranoproliferative Glomerulonephritis",
"has_exemption": false,
"start_date": "2019-10-03",
"completion_date": "2036-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06918002",
"publication_url": "https://clinicaltrials.gov/study/NCT06918002",
"title": "A Phase 3, Open-label, Controlled, Randomized Study of Newly Diagnosed Multiple Myeloma Treatment, Designed to Evaluate the Efficacy and Safety of the Elranatamab-lenalidomide Combination as a Replacement for Chemotherapy Followed by Autologous Stem Cell Transplant in the Consolidation Phase, and to Compare Elranatamab With Standard of Care in the Maintenance Phase",
"has_exemption": false,
"start_date": "2025-07-09",
"completion_date": "2036-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Intergroupe Francophone du Myelome",
"sponsor_slug": "intergroupe-francophone-du-myelome",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07250477",
"publication_url": "https://clinicaltrials.gov/study/NCT07250477",
"title": "Risk-adapted, Proteomic-guided Systemic Therapy for Previously Untreated Advanced Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-01-30",
"completion_date": "2036-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Davis",
"sponsor_slug": "university-of-california-davis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07393373",
"publication_url": "https://clinicaltrials.gov/study/NCT07393373",
"title": "Phase 2, Open-Label, Long-Term, Extension (OLE) Study of Infigratinib, an FGFR 1-3-Selective Tyrosine Kinase Inhibitor, in Children With Hypochondroplasia: ACCEL OLE",
"has_exemption": false,
"start_date": "2026-04-21",
"completion_date": "2036-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "QED Therapeutics, a BridgeBio company",
"sponsor_slug": "qed-therapeutics-a-bridgebio-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05441813",
"publication_url": "https://clinicaltrials.gov/study/NCT05441813",
"title": "A Randomized, Open-label Study of Coconut Oil Mouth Rinse for Prophylaxis of Severe Oral Mucositis in Pediatric Patients Receiving Myeloablative Conditioning Regimens",
"has_exemption": false,
"start_date": "2023-02-15",
"completion_date": "2036-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06342999",
"publication_url": "https://clinicaltrials.gov/study/NCT06342999",
"title": "Evaluation of Outcomes of Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2036-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mauro H. Schenone",
"sponsor_slug": "mauro-h-schenone",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03435796",
"publication_url": "https://clinicaltrials.gov/study/NCT03435796",
"title": "Long-Term Follow-up Protocol for Subjects Treated With Gene-Modified T Cells",
"has_exemption": false,
"start_date": "2018-07-19",
"completion_date": "2036-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Celgene",
"sponsor_slug": "celgene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06072482",
"publication_url": "https://clinicaltrials.gov/study/NCT06072482",
"title": "A Randomized, Double-blind, Placebo-controlled Phase 4 Clinical Trial to Evaluate the Long-term Safety and Efficacy of Avacopan in Participants With Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis",
"has_exemption": false,
"start_date": "2024-02-07",
"completion_date": "2036-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06974279",
"publication_url": "https://clinicaltrials.gov/study/NCT06974279",
"title": "Precision Neuromodulation in Post-Stroke Aphasia Using TMS",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2036-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06932562",
"publication_url": "https://clinicaltrials.gov/study/NCT06932562",
"title": "A Randomized, Open-Label, Controlled Phase 3 Study of Comparing Daratumumab, Lenalidomide and Dexamethasone Induction Followed by Linvoseltamab Versus Continued Daratumumab, Lenalidomide, and Dexamethasone in Newly Diagnosed Transplant Ineligible Multiple Myeloma Patients",
"has_exemption": false,
"start_date": "2025-12-23",
"completion_date": "2036-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "European Myeloma Network B.V.",
"sponsor_slug": "european-myeloma-network-bv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05548972",
"publication_url": "https://clinicaltrials.gov/study/NCT05548972",
"title": "Global, Multicenter and Prospective Post-Market Clinical Follow-Up Study of the G7® Dual Mobility Acetabular System With Vivacit-E® or Longevity® Poly Bearing & Instrumentation",
"has_exemption": false,
"start_date": "2023-03-20",
"completion_date": "2037-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06938399",
"publication_url": "https://clinicaltrials.gov/study/NCT06938399",
"title": "Motiva Implants® Post-Approval Study (PAS) Protocol for Motiva SmoothSilk® Round Ergonomix® ('Ergonomix®') and SmoothSilk® Round ('Round') Breast Implants in Subjects Who Are Undergoing Primary Breast Augmentation, Revision Augmentation and Other Aesthetic Procedures",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2037-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Motiva USA LLC",
"sponsor_slug": "motiva-usa-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03935893",
"publication_url": "https://clinicaltrials.gov/study/NCT03935893",
"title": "A Phase 2 Study to Evaluate the Efficacy and Safety of Adoptive Transfer of Autologous Tumor Infiltrating Lymphocytes in Patients With Advanced Solid Cancers",
"has_exemption": false,
"start_date": "2019-12-03",
"completion_date": "2037-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Udai Kammula",
"sponsor_slug": "udai-kammula",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05201781",
"publication_url": "https://clinicaltrials.gov/study/NCT05201781",
"title": "Long-term Follow-up Study for Participants Previously Treated With Ciltacabtagene Autoleucel",
"has_exemption": false,
"start_date": "2022-03-09",
"completion_date": "2037-07-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06986382",
"publication_url": "https://clinicaltrials.gov/study/NCT06986382",
"title": "Phase 1b/2a Trial of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) From an HLA-partially Matched Related or Unrelated Donor After TCRab+ T-cell/CD19+ B-cell Depletion for Patients With Monogenic and/or Early-onset (EO), Medically Refractory (MR) Crohn Disease (CD)",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2037-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05281809",
"publication_url": "https://clinicaltrials.gov/study/NCT05281809",
"title": "A Feasibility Study Following a Phase 2a Design to Demonstrate Successful Local Manufacture of Chimeric Antigen Receptor (CAR) T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia",
"has_exemption": false,
"start_date": "2022-04-19",
"completion_date": "2037-08-05",
"has_results": false,
"results_due": false,
"sponsor_name": "John Lister",
"sponsor_slug": "john-lister",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07214532",
"publication_url": "https://clinicaltrials.gov/study/NCT07214532",
"title": "SIgnatera-Guided Initiation of Adjuvant CDK4/6 Inhibitor in Intermediate Risk HR+ HER2- Breast Cancer",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2037-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Natera, Inc.",
"sponsor_slug": "natera-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06191744",
"publication_url": "https://clinicaltrials.gov/study/NCT06191744",
"title": "A Phase 3, Multicenter, Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of Epcoritamab + Rituximab and Lenalidomide (R2) Compared to Chemoimmunotherapy in Previously Untreated Follicular Lymphoma (EPCORE™FL-2)",
"has_exemption": false,
"start_date": "2024-02-05",
"completion_date": "2037-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07116473",
"publication_url": "https://clinicaltrials.gov/study/NCT07116473",
"title": "A Phase 3, Open-Label, Multicenter, Extension Study of Acoramidis in Patients With Newly Diagnosed Variant Transthyretin Amyloid Cardiomyopathy (ACT-EARLY OLE)",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2037-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eidos Therapeutics, a BridgeBio company",
"sponsor_slug": "eidos-therapeutics-a-bridgebio-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06651281",
"publication_url": "https://clinicaltrials.gov/study/NCT06651281",
"title": "A Phase 3 Extension Study to Evaluate the Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis",
"has_exemption": false,
"start_date": "2024-11-25",
"completion_date": "2037-12-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05587244",
"publication_url": "https://clinicaltrials.gov/study/NCT05587244",
"title": "Multicenter, Prospective Post-Market Clinical Follow-Up Study of the G7® Freedom Constrained Vivacit-E® Liners",
"has_exemption": false,
"start_date": "2023-05-08",
"completion_date": "2037-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01770418",
"publication_url": "https://clinicaltrials.gov/study/NCT01770418",
"title": "A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2013-03-31",
"completion_date": "2038-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Proton Collaborative Group",
"sponsor_slug": "proton-collaborative-group",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04192591",
"publication_url": "https://clinicaltrials.gov/study/NCT04192591",
"title": "A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)",
"has_exemption": false,
"start_date": "2020-01-30",
"completion_date": "2038-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Scientific Corporation",
"sponsor_slug": "boston-scientific-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07428369",
"publication_url": "https://clinicaltrials.gov/study/NCT07428369",
"title": "A Phase 2/3, Open-Label, Randomized Study of Linvoseltamab, Bortezomib and Lenalidomide (Linvo-VR) With and Without Autologous Stem Cell Transplantation (ASCT) Vs Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) in Transplant-Eligible Participants With Newly Diagnosed Multiple Myeloma",
"has_exemption": false,
"start_date": "2026-06-05",
"completion_date": "2038-05-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03989947",
"publication_url": "https://clinicaltrials.gov/study/NCT03989947",
"title": "A Phase 2 Open-Label Long-Term Extension Study to Evaluate the Safety and Efficacy of BMN 111 in Children With Achondroplasia",
"has_exemption": false,
"start_date": "2019-06-12",
"completion_date": "2038-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BioMarin Pharmaceutical",
"sponsor_slug": "biomarin-pharmaceutical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03538899",
"publication_url": "https://clinicaltrials.gov/study/NCT03538899",
"title": "Phase I/II Safety and Efficacy Study of Gene Transfer for Artemis-Deficient Severe Combined Immunodeficiency (ART-SCID) in Newly Diagnosed Patients Using Self-Inactivating Lentiviral Vector (AProArt) to Transduce Autologous CD34 Hematopoietic Cells",
"has_exemption": false,
"start_date": "2018-05-31",
"completion_date": "2038-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00912041",
"publication_url": "https://clinicaltrials.gov/study/NCT00912041",
"title": "BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia",
"has_exemption": false,
"start_date": "2009-05-31",
"completion_date": "2038-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Leigh R. Hochberg, MD, PhD.",
"sponsor_slug": "leigh-r-hochberg-md-phd",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04081701",
"publication_url": "https://clinicaltrials.gov/study/NCT04081701",
"title": "68Ga(Gallium)-DOTATATE Positron Emission Tomography (PET)/MRI in the Diagnosis and Management of Somatostatin Receptor Positive Central Nervous System CNS Tumors.",
"has_exemption": false,
"start_date": "2019-09-04",
"completion_date": "2038-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05929807",
"publication_url": "https://clinicaltrials.gov/study/NCT05929807",
"title": "A Phase 2, Multicenter, Long-Term, Open Label Extension Trial Evaluating Safety, Tolerability, and Efficacy of Subcutaneous Doses of TransCon CNP Administered Once Weekly in Children and Adolescents With Achondroplasia",
"has_exemption": false,
"start_date": "2023-06-21",
"completion_date": "2039-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ascendis Pharma Growth Disorders A/S",
"sponsor_slug": "ascendis-pharma-growth-disorders-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07226388",
"publication_url": "https://clinicaltrials.gov/study/NCT07226388",
"title": "Hemiarthroplasty Versus Total Shoulder Arthroplasty for the Treatment of Glenohumeral Osteoarthritis: The Impact of Modern Implant Options",
"has_exemption": false,
"start_date": "2026-02-03",
"completion_date": "2039-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06582745",
"publication_url": "https://clinicaltrials.gov/study/NCT06582745",
"title": "Targeted Approach to Langerhans Cell Histiocytosis (LCH) Using MEK Inhibitor, Trametinib",
"has_exemption": false,
"start_date": "2024-06-24",
"completion_date": "2039-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Cook Children's Health Care System",
"sponsor_slug": "cook-childrens-health-care-system",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06498635",
"publication_url": "https://clinicaltrials.gov/study/NCT06498635",
"title": "Randomized Phase III Trial INcorporating Pathologic Complete ReSponse in Participants With Early StaGe Non Small Cell Lung Cancer to Optimize ImmunotHerapy in The AdjuvanT Setting (INSIGHT)",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2039-07-15",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06598371",
"publication_url": "https://clinicaltrials.gov/study/NCT06598371",
"title": "A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2024-11-21",
"completion_date": "2039-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04208529",
"publication_url": "https://clinicaltrials.gov/study/NCT04208529",
"title": "A Long-term Follow-up Study of Subjects With β-thalassemia or Sickle Cell Disease Treated With Autologous CRISPR-Cas9 Modified Hematopoietic Stem Cells (CTX001)",
"has_exemption": false,
"start_date": "2021-01-20",
"completion_date": "2039-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vertex Pharmaceuticals Incorporated",
"sponsor_slug": "vertex-pharmaceuticals-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07431827",
"publication_url": "https://clinicaltrials.gov/study/NCT07431827",
"title": "A Phase 3, Randomized, Double-blind Study of Adjuvant MK-1084 Plus Subcutaneous Pembrolizumab and Berahyaluronidase Alfa (MK-3475A) Versus Adjuvant Placebo Plus MK-3475A in Participants With Completely Resected Stage IIA-IIIB (N2), KRAS G12C-mutant Non-small Cell Lung Cancer Following Receipt of Either Neoadjuvant Pembrolizumab Plus Chemotherapy or Adjuvant Chemotherapy (KANDLELIT-013)",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2039-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02598349",
"publication_url": "https://clinicaltrials.gov/study/NCT02598349",
"title": "A Phase II Trial of Escalated Dose Proton Radiotherapy With Elective Nodal Irradiation and Concomitant Chemotherapy for Patients With Unresectable, Borderline Resectable or Medically Inoperable Pancreatic Adenocarcinoma",
"has_exemption": false,
"start_date": "2016-04-30",
"completion_date": "2039-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Proton Collaborative Group",
"sponsor_slug": "proton-collaborative-group",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06617286",
"publication_url": "https://clinicaltrials.gov/study/NCT06617286",
"title": "MAC-CAR: a Phase 1B/II Trial of Myeloablative Conditioning and Autologous Stem Cell Transplantation Followed by Autologous CD30+ CAR T Cells in Children, Adolescents and Young Adults with Poor-Risk Classical Hodgkin Lymphoma (cHL)",
"has_exemption": false,
"start_date": "2024-12-01",
"completion_date": "2039-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "New York Medical College",
"sponsor_slug": "new-york-medical-college",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03007589",
"publication_url": "https://clinicaltrials.gov/study/NCT03007589",
"title": "Natural Sunlight Protection and Simulated Sunlight Protection Offered by Sunscreens and Fabrics",
"has_exemption": false,
"start_date": "2014-04-30",
"completion_date": "2040-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sun Protection Foundation",
"sponsor_slug": "sun-protection-foundation",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05568719",
"publication_url": "https://clinicaltrials.gov/study/NCT05568719",
"title": "A PHASE 3, NON-INVESTIGATIONAL PRODUCT, MULTI COUNTRY COHORT STUDY TO DESCRIBE THE LONG-TERM SAFETY AND EFFECTIVENESS OF A PRIOR SINGLE-DOSE TREATMENT WITH INVESTIGATIVE GIROCTOCOGENE FITELPARVOVEC OR FIDANACOGENE ELAPARVOVEC IN PARTICIPANTS WITH HEMOPHILIA A OR HEMOPHILIA B, RESPECTIVELY",
"has_exemption": false,
"start_date": "2022-12-28",
"completion_date": "2040-02-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05849480",
"publication_url": "https://clinicaltrials.gov/study/NCT05849480",
"title": "A Phase I/II Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)",
"has_exemption": false,
"start_date": "2024-05-08",
"completion_date": "2040-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02689440",
"publication_url": "https://clinicaltrials.gov/study/NCT02689440",
"title": "Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) With Dasatinib and Venetoclax: A Phase II Study",
"has_exemption": false,
"start_date": "2016-02-19",
"completion_date": "2040-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT07073014",
"publication_url": "https://clinicaltrials.gov/study/NCT07073014",
"title": "A Phase 3, Open-Label, Long-Term Extension Study to Evaluate the Safety and Efficacy of Vosoritide in Children With Hypochondroplasia",
"has_exemption": false,
"start_date": "2025-06-20",
"completion_date": "2040-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BioMarin Pharmaceutical",
"sponsor_slug": "biomarin-pharmaceutical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02760849",
"publication_url": "https://clinicaltrials.gov/study/NCT02760849",
"title": "WISP (Women Choosing Surgical Prevention)",
"has_exemption": false,
"start_date": "2016-05-02",
"completion_date": "2041-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT07095452",
"publication_url": "https://clinicaltrials.gov/study/NCT07095452",
"title": "Phase 2/3, Multicenter, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Subjects With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant",
"has_exemption": false,
"start_date": "2026-01-08",
"completion_date": "2042-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05962346",
"publication_url": "https://clinicaltrials.gov/study/NCT05962346",
"title": "Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion for Severe Left Congenital Diaphragmatic Hernia",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2043-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mauro H. Schenone",
"sponsor_slug": "mauro-h-schenone",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03486873",
"publication_url": "https://clinicaltrials.gov/study/NCT03486873",
"title": "A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants Who Are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab",
"has_exemption": false,
"start_date": "2018-08-21",
"completion_date": "2043-08-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06281730",
"publication_url": "https://clinicaltrials.gov/study/NCT06281730",
"title": "Use of New Generation Fetoscopes in Pregnancies Affected by Fetal Diseases Amenable to Fetoscopy Therapy",
"has_exemption": false,
"start_date": "2024-03-23",
"completion_date": "2044-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06358638",
"publication_url": "https://clinicaltrials.gov/study/NCT06358638",
"title": "Sickle Cell Disease Transplant Using a Nonmyeloablative Approach: Adding Daratumumab for Patients With Anti-donor Red Cell AntibodY",
"has_exemption": false,
"start_date": "2024-04-03",
"completion_date": "2044-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's National Research Institute",
"sponsor_slug": "childrens-national-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01538056",
"publication_url": "https://clinicaltrials.gov/study/NCT01538056",
"title": "Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Juxtarenal Aortic Aneurysm: An Investigator Initiated Study",
"has_exemption": false,
"start_date": "2011-03-31",
"completion_date": "2045-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02917460",
"publication_url": "https://clinicaltrials.gov/study/NCT02917460",
"title": "Genomic Biorepository: Protocol for the Collection, Storage, Analysis, and Distribution of Biological Samples, Genomic and Clinical Data",
"has_exemption": false,
"start_date": "2016-07-31",
"completion_date": "2050-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rady Pediatric Genomics & Systems Medicine Institute",
"sponsor_slug": "rady-pediatric-genomics-systems-medicine-institute",
"status": "ongoing",
"is_pact": true,
"days_late": null
}
]
}